CLINICAL CURATIVE EFFECT OF CYTOKINES COMBINED WITH DOSE-VOLUME HISTOGRAM PARAMETERS AND FEATURES IN PREDICTING RADIATION-INDUCED LUNG INJURY FOR NON-SMALL CELL LUNG CANCER

被引:1
|
作者
Chu, Li [1 ]
Yao, Xuepin [1 ]
Duan, Yingxin [1 ]
机构
[1] Xingtai Med Coll, Dept Radiotherapy & Chemotherapy, Affiliated Hosp 2, Xingtai 054000, Hebei, Peoples R China
来源
ACTA MEDICA MEDITERRANEA | 2022年 / 38卷 / 04期
关键词
Cytokines; Dose-Volume Histogram Parameters; Non-Small Cell Lung Cancer; Radiation-Induced Lung Injury; Predictive Value; RADIOTHERAPY; PNEUMONITIS; IL-6;
D O I
10.19193/0393-6384_2022_4_404
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study aimed to investigate the clinical features of patients with non-small cell lung cancer (NSCLC), the levels of interleukin-1 (IL-1), interleukinn-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) in plasma before and after radiotherapy. Methods: The correlation between dose-volume histogram (DVH) parameters and radiation-induced lung injury (RILI) was also studied. The clinical data of 200 patients with locally advanced NSCLC who received three-dimensional conformal radiotherapy (3D-CRT) in the hospital were retrospectively studied. These patients were divided into an occurrence group and a non-occurrence group. Enzyme-linked immunosorbent assay (ELISA) was adopted for detecting IL-1, IL-6, and TNF-alpha in plasma before and during radiotherapy. V 5, V 10, V 15, V 20, and mean lung dose (MLD) parameters were obtained from DVH, then the correlations between cytokines and DVH parameters as well as RILI were analyzed. Result: The incidence of RILI was 30.5%, and the incidence of RILI with abnormal lung function before radiotherapy was 49.1%, which was higher than 25.5% in patients with normal lung function. IL- 6 level in patients with RILI before radiotherapy was higher than that in the non-occurrence group. The V 5, V 10, and MLD in patients with RILI were higher than those in the non-occurrence group. Conclusion: Multivariate analysis showed that IL-6, V 5, and V 10 were independent risk factors for RILI before radiotherapy. The IL-6 level combined with V 5 and V 10 had a good predictive effect on RILI in patients with NSCLC before radiotherapy.
引用
收藏
页码:2697 / 2704
页数:8
相关论文
共 50 条
  • [31] Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis
    Katsui, Kuniaki
    Ogata, Takeshi
    Watanabe, Kenta
    Katayama, Norihisa
    Soh, Junichi
    Kuroda, Masahiro
    Kiura, Katsuyuki
    Maeda, Yoshinobu
    Toyooka, Shinichi
    Kanazawa, Susumu
    BMC CANCER, 2019, 19 (01)
  • [32] High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis
    Szejniuk, Weronika Maria
    Nielsen, Martin Skovmos
    Takacs-Szabo, Zsuzsanna
    Pawlowski, Jacek
    Al-Saadi, Sahar Sulaiman
    Maidas, Panagiotis
    Bogsted, Martin
    McCulloch, Tine
    Frokjaer, Jens Brondum
    Falkmer, Ursula Gerda
    Roe, Oluf Dimitri
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [33] High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis
    Weronika Maria Szejniuk
    Martin Skovmos Nielsen
    Zsuzsanna Takács-Szabó
    Jacek Pawlowski
    Sahar Sulaiman Al-Saadi
    Panagiotis Maidas
    Martin Bøgsted
    Tine McCulloch
    Jens Brøndum Frøkjær
    Ursula Gerda Falkmer
    Oluf Dimitri Røe
    Radiation Oncology, 16
  • [34] Correction to: Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer
    Hiroto Inoue
    Akira Ono
    Takanori Kawabata
    Nobuaki Mamesaya
    Takahisa Kawamura
    Haruki Kobayashi
    Shota Omori
    Kazushige Wakuda
    Hirotsugu Kenmotsu
    Tateaki Naito
    Haruyasu Murakami
    Kazuaki Yasui
    Hirofumi Ogawa
    Tsuyoshi Onoe
    Masahiro Endo
    Hideyuki Harada
    Toshiaki Takahashi
    Investigational New Drugs, 2021, 39 : 899 - 899
  • [35] Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis
    Kuniaki Katsui
    Takeshi Ogata
    Kenta Watanabe
    Norihisa Katayama
    Junichi Soh
    Masahiro Kuroda
    Katsuyuki Kiura
    Yoshinobu Maeda
    Shinichi Toyooka
    Susumu Kanazawa
    BMC Cancer, 19
  • [36] Influence of Dose and Fractionation in the Radiation Therapy of curative intent for non-small Cell Lung Cancer
    Nieder, Carsten
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (03) : 240 - 242
  • [37] Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy
    Piotrowski, T
    Matecka-Nowak, M
    Milecki, P
    NEOPLASMA, 2005, 52 (01) : 56 - 62
  • [38] Acute pulmonary morbidity following stereotactic body radiotherapy for non-small cell lung cancer: A prospective study of its association with dose-volume histogram parameters
    Paludan, M.
    Traberg Hansen, A.
    Petersen, J.
    Grau, C.
    Hoyer, M.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S483 - S483
  • [39] NTCP models for radiation-induced esophagitis in non-small cell lung cancer
    Carrasco Herrera, M. A.
    Baeza Trujillo, M.
    Lopez Guerra, J. L.
    Montero Perea, E.
    Penalver, R.
    Perez-Luque, S.
    Gomez Puerto, A.
    Herrador Cordoba, M.
    Ortiz, M. J.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S219 - S219
  • [40] Role of dose volume histogram in the evaluation of radiation-induced esophageal and lung toxicity in patients with locally advanced Non Small Cell Lung Cancer (NSCLC): a retrospective analysis
    Mantovani, Cristina
    Todisco, Liana
    Levra, Giaj Niccolo
    Filippi, Andrea
    Guarneri, Alessia
    Ciammella, Patrizia
    Iftode, Cristina
    Ragona, Riccardo
    Botticella, Angela
    Ricardi, Umberto
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S951 - S952